Ginkgo won AI Breakthrough Award for drug discovery
Its autonomous lab pairs frontier models with lab infrastructure to speed experimentation and cut costs.
See the latest news and media coverage for Ginkgo. We track all announcements, press releases, and industry mentions in real time, all in one place.
Autonomous lab platform for biotechnology R&D
ginkgo.bioLast updated
In short: Ginkgo launched autonomous lab services, including Ginkgo Cloud Lab, while undergoing a major restructuring and leadership changes.
Its autonomous lab pairs frontier models with lab infrastructure to speed experimentation and cut costs.
The platform integrates data generation, AI-driven PK projection, and compound management for early-stage drug discovery.
It uses Nebula, an autonomous lab, to produce pharmaceuticals domestically, achieving a milestone with GFP production.
Revenue fell to $19M from $38M, net loss narrowed to $76M, and Nebula lab expansion targets doubling size.
Ginkgo Bioworks draws attention as healthcare strength meets caution around synthetic biology, platform growth, and execution.
High Yield- Join thousands of investors using free stock market insights and expert analysis to identify stronger growth opportunities before major price moves. Ginkgo Bioworks...
As of Friday, May 08, Ginkgo Bioworks Holdings, Inc.'s DNA share price has dipped by 13.95%, which has investors questioning if this is right time...
BOSTON, March 2, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to...
Track Ginkgo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Ginkgo and other trending companies.